Search

everythinglearnresearchcommunity

for

Search:↓

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Certain drugs that block specific enzymes can help treat prostate diseases.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Certain mutations in the H6PD gene cause Cortisone Reductase Deficiency by affecting hormone production.

Finasteride and dutasteride are effective for male hair loss and enlarged prostate but may cause reversible sexual side effects.

The study created a new method to test drugs that affect hormone processing in skin.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Dutasteride reduces DHT and improves BPH symptoms more effectively than finasteride.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

Camellia oleifera seed shell polyphenols and 1,3,6-tri-O-galloylglucose can help treat hair loss by reducing certain hormones and promoting hair growth.

Ishophloroglucin A from Ishige okamurae may be a natural alternative for treating hair loss by inhibiting 5α-reductase and promoting hair growth.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

The main enzyme found in pubic skin that could be targeted to treat excessive hair growth is 5 alpha-R2.

The study found that two enzymes linked to hair loss are located in different parts of the scalp, supporting a common treatment's effectiveness.

Finasteride doesn't affect ovulation in normal women.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

Finasteride reduces hair growth in women with hirsutism and works better with electrolysis.

Finasteride inhibits enzyme activity in rhesus macaques, suggesting they're useful for evaluating similar drugs.

The enzyme type 1 5α-reductase is more active in the hair follicle's lower part than in the skin's outer layer.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

Steroid hormones are crucial for body functions and have various medical uses, but their misuse can lead to dependence.

Dutasteride is more effective than finasteride for hair loss treatment.

Hesperidin protects rat testicles from finasteride damage and improves sperm health.

Trazodone might help reverse post finasteride syndrome.